drugset / Trial / NCT00455923
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
RandomizedParallel-groupTreatment
Summary
An 18 months randomised double-blind study with two parallel arms with start dose of inhaled SERETIDE 50/100mcg BD or FLIXOTIDE 100mcg BD, Phase I is 6 months where the patient will be up-titrated until well controlled is achieved, After 6 months the treatment continues without changes during 9 months = PhaseII. The aim is to investigate and evaluate the assumption that the combination therapy with SERETIDE controls mild persistent asthma better than inhaled corticosteroids(FLIXOTIDE) alone.
Timeline
- Start
- 2005-05-03
- Primary completion
- 2007-07-31
- Completion
- 2007-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 100 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 250 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |
| Subject | Sal | Unknown | 50 ug | Inhaled |